1. Lyme Disease Diagnostic Devices Market Overview
1.1 Definitions and Scope
2. Lyme Disease Diagnostic Devices Market Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Diagnostic Technologies type
2.3 Key trends by Diagnostic Tests
2.4 Key trends by End-User Industry
2.5 Key trends by Geography
3. Lyme Disease Diagnostic Devices Market Landscape
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis – Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Lyme Disease Diagnostic Devices Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. Lyme Disease Diagnostic Devices Market Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Lyme Disease Diagnostic Devices Market – By Diagnostic Technologies type (Market Size -$Million/$Billion)
6.1 Molecular diagnostics
6.2 Brain MRI
6.3 Spinal tap
6.4 Echocardiogram
6.5 Electrocardiogram
6.6 Monoclonal antibodies
6.7 Flow cytometry
6.8 Gel microdroplets
6.9 Others
7. Lyme Disease Diagnostic Devices Market– By Diagnostic Tests (Market Size -$Million/$Billion)
7.1 Serological Test
7.2 Nucleic Acid Amplification
7.3 Urine Antigen Tests
7.4 Lymphocytic Transformation Test
7.5 Immunofluorescent Staining
7.6 PCR Analysis
7.7 Others
8. Lyme Disease Diagnostic Devices Market – By End-User Industry (Market Size -$Million/$Billion)
8.1 Hospitals
8.2 Pathology labs
8.3 Pharmaceutical Industries
8.4 Clinical Research Institute
9. Lyme Disease Diagnostic Devices Market – By Geography (Market Size -$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.1.4 Rest of North America
9.2 Europe
9.2.1 U.K.
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 France
9.2.6 Netherlands
9.2.7 Spain
9.2.8 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 Rest of Asia-Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Africa
9.4.3 South America
10. Lyme Disease Diagnostic Devices Market Entropy
11. Lyme Disease Diagnostic Devices Market Company Analysis
11.1 Company Revenue, Products, M&A, Developments
11.2 Abbott Laboratories
11.3 Canon U.S. Life Sciences
11.4 Biosystems
11.5 Bio-Rad Laboratories
11.6 Immunetics Inc
11.7 Roche Diagnostics International Ltd.
11.8 T2 Biosystems
11.9 Graphene Frontiers,
11.10 Alere Inc (ALR)
11.11 Boulder Diagnostics
“*Financials for private companies would be provided on a best efforts basis”.
IndustryARC
I 기본 3,500,000원부터~
Report Description
Overview
라임병 진단 장치는 라임병의 초기 진단과 관리에 필수적입니다. 주요 기술은 혈청 검사, PCR 분석, 분자 진단 등을 포함하며, 진단 속도와 정확성이 중요합니다.
Segment
기술 유형에는 분자 진단, MRI, 척수 천자, 단클론 항체 등이 포함되며, 주요 최종 사용자는 병원, 병리학 연구소 및 임상 연구 기관입니다.
Key Takeaways
증가하는 라임병 사례와 초기 진단의 중요성이 시장 성장을 촉진하고 있습니다. 특히, 북미와 유럽에서의 기술 개발과 투자 확대로 인해 시장 확장이 기대됩니다.